What Is End-of-Life Care for Undifferentiated Pleomorphic Sarcoma (UPS)?
By CRYSTAL BAI •
The short answer: Undifferentiated pleomorphic sarcoma (UPS) is an aggressive high-grade soft tissue sarcoma. End-of-life care manages metastatic lung disease, local recurrence, pain, and cachexia through specialized palliative care, with early hospice enrollment when systemic therapy options are exhausted.
Understanding UPS at End of Life
Undifferentiated pleomorphic sarcoma (UPS) — formerly called malignant fibrous histiocytoma (MFH) — is one of the most common high-grade soft tissue sarcomas in adults. Despite aggressive surgery, radiation, and chemotherapy, recurrence and metastasis (most often to the lungs) occur in a significant proportion of patients with high-grade disease.
Metastatic Disease Management
Pulmonary metastases are the most common site of distant spread, causing dyspnea, cough, and eventually respiratory compromise. Bone metastases cause pain. Local recurrence in the extremity or retroperitoneum may cause pain, swelling, and functional impairment. Palliative interventions include radiation for symptomatic metastases, opioid analgesics, and pulmonary symptom management.
When Systemic Therapy Options Are Exhausted
After failure of first-line (doxorubicin-based) and second-line (gemcitabine, trabectedin, pazopanib) therapies, most UPS patients have limited further treatment options. This transition is often the trigger for goals-of-care conversations and hospice planning.
Functional Decline and Quality of Life
UPS often affects limb function when located in the extremities, and retroperitoneal UPS affects GI and urologic function. Preserving functional independence and quality of life for as long as possible — through PT/OT, assistive devices, and symptom management — is a key palliative care goal.
Frequently Asked Questions
What is undifferentiated pleomorphic sarcoma (UPS)?
UPS is a high-grade soft tissue sarcoma (formerly called malignant fibrous histiocytoma) with a propensity for local recurrence and lung metastasis.
When should a UPS patient consider hospice?
Hospice is appropriate when UPS is progressing after standard chemotherapy regimens, prognosis is six months or less, and the focus shifts to comfort care.
What symptoms are managed at end of life with UPS?
Key symptoms include dyspnea from lung metastases, pain from local recurrence or bone involvement, and functional decline.
Can a death doula help a patient with UPS?
Yes. A death doula provides companionship, legacy work, family guidance, and can help navigate the transition from treatment to comfort care for sarcoma patients.
Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.